LONG-TERM TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) INTHALASSEMIA - REDUCTION IN REQUIREMENT FOR TRANSFUSION AND CHELATION-THERAPY

Citation
Gd. Sher et al., LONG-TERM TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) INTHALASSEMIA - REDUCTION IN REQUIREMENT FOR TRANSFUSION AND CHELATION-THERAPY, Blood, 84(10), 1994, pp. 10000258-10000258
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
84
Issue
10
Year of publication
1994
Supplement
1
Pages
10000258 - 10000258
Database
ISI
SICI code
0006-4971(1994)84:10<10000258:LTWR(I>2.0.ZU;2-T